Crossmark

Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer

Crossref DOI link: https://doi.org/10.1186/s12951-020-00701-7

Published Online: 2020-10-22

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sancho-Albero, María

Sebastián, Víctor

Sesé, Javier

Pazo-Cid, Roberto

Mendoza, Gracia

Arruebo, Manuel

Martín-Duque, Pilar https://orcid.org/0000-0003-4160-9720
Santamaría, Jesús
Funding

Funding for this research was provided by:

European Research Council (ERC-2016-ADG-742684, CADENCE)

Instituto de Salud Carlos III (PI19/01007)

Gobierno de Aragón (T57_17R p)
License Information

Text and Data Mining valid from 2020-10-22

Version of Record valid from 2020-10-22
More Information

Article History

Received: 21 April 2020

Accepted: 5 October 2020

First Online: 22 October 2020

Ethics approval and consent to participate

: All the assays involving human materials were approved by the Research Ethics Committee of the Community of Aragon (<i>Comité de Ética de la Investigación de la Comunidad de Aragón -CEICA-): Extracción de exosomas de tumores y plasma de pacientes con diversos grados de malignidad, para el estudio de su composición y correlación clínica, PI18/198</i>. Participants provided their written informed consent to participate in this study.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below